Viewing Study NCT00282932


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-01-01 @ 7:20 PM
Study NCT ID: NCT00282932
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2006-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Detrol LA In Men With Overactive Bladder.
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01
Start Date Type: None
Primary Completion Date: 2007-05-01
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05-14
Completion Date Type: ACTUAL
First Submit Date: 2006-01-26
First Submit QC Date: None
Study First Post Date: 2006-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-01-26
Last Update Post Date: 2021-01-27
Last Update Post Date Type: ACTUAL